EDWIN KOLODNY, M.D.
Neurology at 34 St, New York, NY
License number
New York 091581
Category
Neurology
Type
Neurology
Address
Address
403 E 34Th St FL 2, New York, NY 10016
Phone
(212) 263-8344
Personal information
See more information about EDWIN KOLODNY at radaris.comName
Address
Phone
110 Bleecker St, New York, NY 10012
1 Fountain Ln, Scarsdale, NY 10583
6 Meadowlark Condominiums, New York, NY 10012
Organization information
See more information about EDWIN KOLODNY at bizstanding.comEdwin Kolodny MD
550 1 Ave, New York, NY 10016
Industry:
Genetic Medicine, Neurologist
Phone:
(212) 263-6347 (Phone)
Edwin Hillel Kolodny
Professional information
Edwin H Kolodny, New York NY
Specialties:
Neurologist
Address:
550 1St Ave, New York, NY 10016
403 E 34Th St, New York, NY 10016
403 E 34Th St, New York, NY 10016
Education:
New York University, School of Medicine - Doctor of Medicine
Massachusetts General Hospital - Fellowship - Neurology
Massachusetts General Hospital - Fellowship - Neuropathology (Pathology)
Massachusetts General Hospital - Residency - Neurology
Bellevue Hospital Center - Residency - Internal Medicine
Massachusetts General Hospital - Fellowship - Neurology
Massachusetts General Hospital - Fellowship - Neuropathology (Pathology)
Massachusetts General Hospital - Residency - Neurology
Bellevue Hospital Center - Residency - Internal Medicine
Board certifications:
American Board of Medical Genetics Certification in Clinical Biochemical Genetics (Medical Genetics), American Board of Medical Genetics Certification in Clinical Genetics (MD) (Medical Genetics), American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)
Dr. Edwin Kolodny, New York NY - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology), Clinical Biochemical Genetics, Clinical Genetics
Address:
550 1St Ave SUITE 10S, New York 10016
(212) 263-8344 (Phone), (212) 263-8310 (Fax)
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
403 E 34Th St SUITE 2, New York 10016
(212) 263-8344 (Phone), (212) 263-8310 (Fax)
(212) 263-8344 (Phone), (212) 263-8310 (Fax)
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
403 E 34Th St SUITE 2, New York 10016
(212) 263-8344 (Phone), (212) 263-8310 (Fax)
Certifications:
Clinical Biochemical Genetics, 1987, Clinical Genetics, 1984, Neurology, 1971
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
550 1St Ave SUITE 10S, New York 10016
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
403 E 34Th St SUITE 2, New York 10016
NYU Langone Medical Center
550 1St Ave, New York 10016
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
403 E 34Th St SUITE 2, New York 10016
NYU Langone Medical Center
550 1St Ave, New York 10016
Education:
Medical School
New York University
Graduated: 1962
Bellevue Hospital Center
Massachusetts General Hospital
Harvard Medical School
Mass Genl Hosp
Natl Inst Neurol Dis & Stroke
New York University
Graduated: 1962
Bellevue Hospital Center
Massachusetts General Hospital
Harvard Medical School
Mass Genl Hosp
Natl Inst Neurol Dis & Stroke
Edwin H Kolodny, New York NY
Specialties:
Neurology, Medical Genetics, Clinical Biochemical Genetics, Clinical Genetics, M.D.
Work:
NYU Hospitals Center
403 E 34Th St, New York, NY 10016 NYU Hospitals Center
550 1St Ave, New York, NY 10016
403 E 34Th St, New York, NY 10016 NYU Hospitals Center
550 1St Ave, New York, NY 10016
Education:
New York University (1962)
Methods Of Diagnosis, Monitoring And Staging Of Various Conditions Using Igg Antibodies Against Hydroxy-Fatty Acid Containing Sulfatide
US Patent:
5674690, Oct 7, 1997
Filed:
Sep 29, 1995
Appl. No.:
8/536940
Inventors:
Edwin H. Kolodny - New York NY
Srinavasa Raghavan - North Brunswick NJ
Miguel Angel Gama Sosa - New York NY
Rita De Gasperi - New York NY
Srinavasa Raghavan - North Brunswick NJ
Miguel Angel Gama Sosa - New York NY
Rita De Gasperi - New York NY
Assignee:
New York University - New York NY
International Classification:
G01N 3353, G01N 33537, G01N 33543, G01N 33564
US Classification:
435 71
Abstract:
A method for screening for, diagnosing, monitoring or staging of multiple sclerosis, HIV infection, rheumatoid arthritis or systemic lupus erythematosus in a subject, is based on the detection of IgG antibodies against the hydroxy-fatty acid form of sulfatide in a tissue or body fluid sample of the subject. The presence of such IgG levels substantially above those in healthy controls is indicative of an increased likelihood that the subject has one of such conditions.
Canine .Beta.-Galactosidase Gene And Gm1-Gangliosidosis
US Patent:
6140115, Oct 31, 2000
Filed:
Nov 9, 1999
Appl. No.:
9/436605
Inventors:
Edwin H. Kolodny - New York NY
Zhao-Hui Wang - Flushing NY
Srinivasa Raghavan - North Brunswick NJ
Baijin Zeng - Flushing NY
Zhao-Hui Wang - Flushing NY
Srinivasa Raghavan - North Brunswick NJ
Baijin Zeng - Flushing NY
International Classification:
C12N 1512, C12N 938
US Classification:
4353201
Abstract:
The acid. beta. -galactosidase cDNA of Portuguese Water (PW) dogs was isolated and sequenced. The entire encoding region of the gene consists of 2004 nucleotides coding a protein of 668 amino acids. Its encoding sequence indicates approximately 86. 5% identity at the nucleotide level and about 81% identity at the amino acid level with the encoding region of the human acid. beta. -galactosidase gene. The deduced amino acid sequence contains a 24-amino acid putative signal sequence, 6 possible glycosylation sites, and 7 cysteine residues. A homozygous recessive mutation, causing G. sub. M1 -gangliosidosis in PW dogs, was identified at nucleotide G. sup. 200. fwdarw. A in exon 2 resulting in an Arg. sup. 60. fwdarw. His (mutation R60H) amino acid substitution. The mutation creates a new restriction enzyme site for PmlI.